TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 1 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $69,000 | +13.1% | 51,274 | -4.7% | 0.00% | – |
Q4 2018 | $61,000 | -51.6% | 53,787 | +17.7% | 0.00% | – |
Q3 2018 | $126,000 | -22.2% | 45,687 | +0.9% | 0.00% | – |
Q2 2018 | $162,000 | -50.0% | 45,282 | -11.9% | 0.00% | – |
Q4 2017 | $324,000 | -8.2% | 51,382 | -0.5% | 0.00% | – |
Q3 2017 | $353,000 | +3.8% | 51,639 | +8.4% | 0.00% | – |
Q2 2017 | $340,000 | -57.8% | 47,633 | -45.7% | 0.00% | – |
Q1 2017 | $806,000 | +475.7% | 87,682 | +152.8% | 0.00% | – |
Q4 2016 | $140,000 | +17.6% | 34,690 | +11.7% | 0.00% | – |
Q3 2016 | $119,000 | -10.5% | 31,067 | +0.7% | 0.00% | – |
Q2 2016 | $133,000 | -93.8% | 30,843 | -31.3% | 0.00% | -100.0% |
Q2 2015 | $2,129,000 | +29.4% | 44,883 | -0.0% | 0.00% | 0.0% |
Q1 2015 | $1,645,000 | +18.9% | 44,895 | +28.9% | 0.00% | 0.0% |
Q4 2014 | $1,383,000 | -11.5% | 34,817 | -55.5% | 0.00% | 0.0% |
Q3 2014 | $1,562,000 | +2197.1% | 78,303 | +1466.1% | 0.00% | – |
Q4 2013 | $68,000 | +47.8% | 5,000 | +25.0% | 0.00% | – |
Q3 2013 | $46,000 | – | 4,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
683 Capital Management, LLC | 600,000 | $2,142,000 | 0.14% |
Tekla Capital Management LLC | 859,322 | $3,068,000 | 0.12% |
DOW CHEMICAL CO /DE/ | 65,000 | $232,000 | 0.08% |
Candriam S.C.A. | 495,613 | $1,769,000 | 0.03% |
A.R.T. Advisors, LLC | 174,335 | $622,000 | 0.02% |
Baker Brothers Advisors | 935,000 | $3,338,000 | 0.02% |
FLAGSHIP HARBOR ADVISORS, LLC | 29,400 | $104,000 | 0.02% |
Alambic Investment Management, L.P. | 17,804 | $64,000 | 0.02% |
Teton Advisors, Inc. | 44,000 | $157,000 | 0.01% |
Man Group plc | 737,715 | $2,634,000 | 0.01% |